Characterizing the cancer genome in lung adenocarcinoma

Nature

Volumn 450, Issue 7171, 2007, Pages 893-898

  Weir, Barbara A ^a,b   Woo, Michele S ^a   Getz, Gad ^b   Perner, Sven ^c,d   Ding, Li ^e   Beroukhim, Rameen ^a,b   Lin, William M ^a,b   Province, Michael A ^e   Kraja, Aldi ^e   Johnson, Laura A ^c   Shah, Kinjal ^a,b   Sato, Mitsuo ^f   Thomas, Roman K ^a,b,g,h   Barletta, Justine A ^c   Borecki, Ingrid B ^e   Broderick, Stephen ⁱ   Chang, Andrew C ^j   Chiang, Derek Y ^a,b   Chirieac, Lucian R ^c,k   Cho, Jeonghee ^a   Fujii, Yoshitaka ^l   Gazdar, Adi F ^f   Giordano, Thomas ^j   Greulich, Heidi ^a,b   Hanna, Megan ^a,b   Johnson, Bruce E ^a   Kris, Mark G ⁱ   Lash, Alex ⁱ   Lin, Ling ^e   Lindeman, Neal ^c,k   Mardis, Elaine R ^e   McPherson, John D ^m   Minna, John D ^f   Morgan, Margaret B ^m   Nadel, Mark ^a,b   Orringer, Mark B ^j   Osborne, John R ^e   Ozenberger, Brad ⁿ   Ramos, Alex H ^a,b   Robinson, James ^b   Roth, Jack A ^o   Rusch, Valerie ⁱ   Sasaki, Hidefumi ^l   Shepherd, Frances ^p   Sougnez, Carrie ^b   Spitz, Margaret R ^o   Tsao, Ming Sound ^p   Twomey, David ^b   Verhaak, Roel G W ^b   Weinstock, George M ^m   Wheeler, David A ^m   Winckler, Wendy ^a,b   Yoshizawa, Akihiko ⁱ   Yu, Soyoung ^a   Zakowski, Maureen F ⁱ   Zhang, Qunyuan ^e   Beer, David G ^j   Wistuba, Ignacio I ^o   Watson, Mark A ^e   Garraway, Levi A ^a,b   Ladanyi, Marc ⁱ   Travis, William D ⁱ   Pao, William ⁱ   Rubin, Mark A ^b,c   Gabriel, Stacey B ^b   Gibbs, Richard A ^m   Varmus, Harold E ⁱ   Wilson, Richard K ^e   Lander, Eric S ^b,k   Meyerson, Matthew ^a,b,k   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF ULM   (Germany)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^m BAYLOR COLLEGE OF MEDICINE   (United States)

ⁿ NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^o UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^p PRINCESS MARGARET HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NK2 HOMEOBOX 1 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARRAY; CANCER; CHROMOSOME; DNA; GENETIC ANALYSIS; GENOME; MUTATION; RESPIRATORY DISEASE; TUMOR;

ARTICLE; CANCER RECURRENCE; CHROMOSOME; CHROMOSOME 14Q; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENOME ANALYSIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOMA; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 36248980204     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06358     Document Type: Article

References (42)

1. Weir, B., Zhao, X. & Meyerson, M. Somatic alterations in the human cancer genome. Cancer Cell 6, 433-438 (2004).
2. Sawyers, C. Targeted cancer therapy. Nature 432, 294-297 (2004).
3. Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20, 207-211 (1998).
4. Pollack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genet. 23, 41-46 (1999).
5. Bignell, G. R. et al. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res. 14, 287-295 (2004).
6. Zhao, X. et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 64, 3060-3071 (2004).
7. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122 (2005).
8. Zhao, X. et al. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res. 65, 5561-5570 (2005).
9. Li, C. & Wong, W. H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl Acad. Sci. USA 98, 31-36 (2001).
10. Li, C. & Wong, W. H. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2, RESEARCH0032 (2001).
11. Hupe, P., Stransky, N., Thiery, J. P., Radvanyi, F. & Barillot, E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20, 3413-3422 (2004).
12. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc. Natl Acad Sci. USA. (in the press).
13. Balsara, B. R. & Testa, J. R. Chromosomal imbalances in human lung cancer. Oncogene 21, 6877-6883 (2002).
14. Garnis, C. et al. High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGH. Int. J. Cancer 118, 1556-1564 (2006).
15. Tonon, G. et al. High-resolution genomic profiles of human lung cancer. Proc. Natl Acad. Sci. USA 102, 9625-9630 (2005).
16. Hayashi, N., Sugimoto, Y., Tsuchiya, E., Ogawa, M. & Nakamura, Y. Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem. Biophys. Res. Commun. 202, 1426-1430 (1994).
17. Sanchez-Cespedes, M. et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62, 3659-3662 (2002).
18. Takahashi, T. et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491-494 (1989).
19. Sato, M. et al. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer 44, 405-414 (2005).
20. Cox, C. et al. A survey of homozygous deletions in human cancer genomes. Proc. Natl Acad. Sci. USA 102, 4542-4547 (2005).
21. Barnes, A. P. et al. Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane of the airway epithelium. J. Biol. Chem. 280, 7997-8003 (2005).
22. Zhu, C. Q. et al. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br. J. Cancer 94, 1452-1459 (2006).
23. Zhang, A. et al. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 60, 6230-6235 (2000).
24. Johnson, D. H. et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J. Clin. Oncol. 22, 2184-2191 (2004).
25. Sandler, A. et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N. Engl. J. Med. 355, 2542-2550 (2006).
26. Bingle, C. D. Thyroid transcription factor-1. Int. J. Biochem. Cell Biol. 29, 1471-1473 (1997).
27. Ikeda, K. et al. Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J. Biol. Chem. 270, 8108-8114 (1995).
28. -/- embryos. Dev. Dyn. 217, 180-190 (2000).
29. Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764 (2007).
30. Bamford, S. et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br. J. Cancer 91, 355-358 (2004).
31. Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177-183 (2004).
32. Reich, M. et al. GenePattern 2.0. Nature Genet. 38, 500-501 (2006).
33. Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high-density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193 (2003).
34. Iafrate, A. J. et al. Detection of large-scale variation in the human genome. Nature Genet. 36, 949-951 (2004).
35. Lin, M. et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20, 1233-1240 (2004).
36. Rozen, S. & Skaletsky, H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386 (2000).
37. Nickerson, D. A., Tobe, V. O. & Taylor, S. L. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745-2751 (1997).
38. Rubin, M. A. et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 64, 3814-3822 (2004).
39. Phelps, R. M. et al. NCI-Navy Medical Oncology Branch cell line data base. J. Cell. Biochem., Suppl. 24, 32-91 (1996).
40. Banks-Schlegel, S. P., Gazdar, A. F. & Harris, C. C. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines. Cancer Res. 45, 1187-1197 (1985).
41. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
42. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15, 871-875 (1997).